FDA Adverse Event Injury Summary report: N

CLEARCORRECT SYSTEM

MDR report key: 10610262 · Received September 30, 2020

Report

Report Number
3007130440-2020-00002
Event Type
Injury
Date Received
September 30, 2020
Date of Event
September 4, 2020
Report Date
September 30, 2020
Manufacturer
CLEARCORRECT LLC
Product Code
NXC
UDI-DI
D865REF00011
PMA / PMN Number
K113618
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
DENTIST

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION FINDINGS: THE CUSTOMER SENT IN SCREENSHOTS OF A TEXT CONVERSATION WITH THE PATIENT. PATIENT STATES AFTER OPENING STEP 5 AND WEARING IT HER LIPS, TONGUE, AND INSIDE OF HER MOUTH SWELLED UP. PATIENT WENT TO URGENT CARE WHERE SHE WAS GIVEN AN EPIPEN AND OTHER MEDICATIONS FOR THE REACTION. A REVIEW OF BATCH 253799 WAS PERFORMED WHERE IT WAS CONFIRMED THERE WERE NO SIMILAR COMPLAINTS, THUS THE EVENT WAS ISOLATED TO THIS CASE. CLINICAL EVALUATION: AN ALLERGIC REACTION CAN BE A MODERATE MEDICAL RISK TO THE PATIENT. REGULATORY EVALUATION: THIS EVENT OCCURRED AT THE START OF TREATMENT STEP 5; THE ACCOUNT DID NOT INDICATE IF THE PATIENT EXHIBITED ANY SIGNS OF ALLERGIC REACTION DURING STEPS 1 TO 4. WHILE THE COMPLAINT IMPLIES AN ALLERGIC REACTION, IT IS NOT CERTAIN THAT IT IS ASSOCIATED WITH THE DEVICE. BECAUSE THE EVENT DID NOT OCCUR UNTIL STEP 5, IT IS NOT AN ACUTE REACTION THAT WOULD REQUIRE MEDICAL INTERVENTION TO AVOID PERMANENT HARM OR DEATH. THE PATIENT DID SEEK MEDICAL TREATMENT AND WAS PRESCRIBED AN EPIPEN. IT IS NOT CLEAR WHETHER THE EPIPEN OR SOME OTHER INTERVENTION WAS AT THE TIME THE PATIENT SOUGHT TREATMENT. BECAUSE IT APPEARS THAT MEDICAL INTERVENTION WAS PERFORMED IN THIS EVENT, THIS EVENT MEETS THE CRITERIA FOR ADVERSE EVENT REPORTING.

Description of Event or Problem · 1

THE PATIENT'S LIPS, TONGUE, AND MOUTH SWELLED UP.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1074108 CLEARCORRECT SYSTEM CLEAR PLASTIC ORTHODONTIC ALIGNER NXC CLEARCORRECT LLC Aligner (Single-Layer) 253799 D865REF00011

Patients

Seq Age Sex Outcome Treatment
1 35 YR Required Intervention